Stockscreener 앱 받기
178.84
0.69%
-1.455
전일 마감가:
$180.29
열려 있는:
$181.15
하루 거래량:
2.28M
Relative Volume:
0.40
시가총액:
$284.46B
수익:
$113.10B
순이익/손실:
$16.33B
주가수익비율:
18.36
EPS:
9.7425
순현금흐름:
$10.35B
1주 성능:
+1.44%
1개월 성능:
+5.37%
6개월 성능:
+35.73%
1년 성능:
+39.98%
1일 변동 폭
$178.06
$181.15
1주일 범위
$176.06
$181.98
52주 변동 폭
$94.33
$181.98
모건 스탠리 Stock (MS) Company Profile
명칭
Morgan Stanley
전화
212-761-4000
주소
1585 BROADWAY, NEW YORK, NY
MS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MS
Morgan Stanley
|
178.99 | 286.54B | 113.10B | 16.33B | 10.35B | 9.7425 |
|
GS
Goldman Sachs Group Inc
|
897.39 | 273.24B | 126.58B | 16.67B | 57.26B | 49.23 |
|
SCHW
Charles Schwab Corp
|
96.38 | 172.45B | 27.16B | 8.23B | 20.55B | 4.2633 |
|
HOOD
Robinhood Markets Inc
|
121.43 | 110.94B | 4.23B | 2.19B | -4.36B | 2.4089 |
|
LPLA
Lpl Financial Holdings Inc
|
385.94 | 31.01B | 14.13B | 1.12B | 45.45M | 14.62 |
모건 스탠리 Stock (MS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-24 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-10-03 | 개시 | BMO Capital Markets | Outperform |
| 2025-07-09 | 업그레이드 | Keefe Bruyette | Mkt Perform → Outperform |
| 2024-11-26 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2024-11-15 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2024-10-04 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-09-11 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-08-02 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2024-07-17 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-01-17 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-01-17 | 다운그레이드 | Keefe Bruyette | Outperform → Mkt Perform |
| 2024-01-09 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2023-11-28 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2023-11-20 | 다운그레이드 | Exane BNP Paribas | Outperform → Neutral |
| 2023-10-23 | 다운그레이드 | Odeon | Buy → Hold |
| 2023-10-20 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2023-10-11 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-09-07 | 개시 | HSBC Securities | Buy |
| 2023-07-12 | 업그레이드 | Odeon | Hold → Buy |
| 2023-01-18 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-01-10 | 업그레이드 | Odeon | Sell → Hold |
| 2023-01-04 | 다운그레이드 | Wolfe Research | Outperform → Underperform |
| 2022-10-05 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2022-09-06 | 다운그레이드 | Odeon | Hold → Sell |
| 2022-05-03 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2022-01-28 | 다운그레이드 | Odeon | Buy → Hold |
| 2021-12-03 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-10-15 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-10-04 | 재확인 | Jefferies | Buy |
| 2021-09-29 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-09-28 | 다운그레이드 | Berenberg | Buy → Hold |
| 2021-08-13 | 다운그레이드 | Seaport Global Securities | Buy → Neutral |
| 2021-07-07 | 재개 | Keefe Bruyette | Outperform |
| 2021-06-09 | 개시 | Jefferies | Buy |
| 2021-04-21 | 업그레이드 | Berenberg | Hold → Buy |
| 2021-03-02 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2021-01-06 | 개시 | Daiwa Securities | Neutral |
| 2021-01-04 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-11-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-10-13 | 재개 | JP Morgan | Overweight |
| 2020-07-08 | 개시 | Seaport Global Securities | Buy |
| 2020-06-24 | 업그레이드 | DA Davidson | Neutral → Buy |
| 2020-06-23 | 재확인 | UBS | Buy |
| 2020-05-21 | 업그레이드 | Odeon | Hold → Buy |
| 2020-04-14 | 업그레이드 | Societe Generale | Sell → Buy |
| 2020-03-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-02-21 | 다운그레이드 | DA Davidson | Buy → Neutral |
| 2020-02-20 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-01-21 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-01-17 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-01-13 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2020-01-09 | 개시 | DA Davidson | Buy |
| 2020-01-06 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2019-10-29 | 다운그레이드 | Odeon | Buy → Hold |
| 2019-10-10 | 업그레이드 | Sandler O'Neill | Hold → Buy |
| 2019-07-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-04-18 | 다운그레이드 | Citigroup | Buy → Neutral |
모두보기
모건 스탠리 주식(MS)의 최신 뉴스
Veteran Morgan Stanley PM to retire, step off $2bn in funds - Citywire
Fed Cuts Rate: Will This Accelerate Morgan Stanley's IB Fee Growth? - The Globe and Mail
Rhythm Pharmaceuticals Phase 2 Setmelanotide Data Show 'Encouraging' Early Activity, Morgan Stanley Says - marketscreener.com
Ciena Seeing Strong Demand Aided by 'Leadership' Positions, Morgan Stanley Says - marketscreener.com
REGEuronext DublinGEM-MSIP- Partial Retirement12.12.2025 (MORGAN STANLEY & CO. INTERNATIONAL PLC) [85678] - TradingView
Morgan Stanley Stock (MS) Today: Shares Hover Near Record Levels as Fed Cuts Rates, Analysts Update Targets Ahead of Q4 Earnings - ts2.tech
Morgan Stanley B.V. announces partial cancellation of securities - Investing.com
Morgan Stanley B.V. announces partial cancellation of securities By Investing.com - Investing.com Australia
Morgan Stanley highlights four European gambling stocks to own in 2026 - Investing.com UK
Morgan Stanley Adjusts Amgen Price Target to $304 From $329, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley Adjusts Moderna Price Target to $28 From $30, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley Adjusts Regeneron Pharmaceuticals PT to $768 From $767, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley Adjusts Price Target on AbbVie to $269 From $261, Maintains Overweight Rating - marketscreener.com
Morgan Stanley Adjusts Merck & Co. PT to $102 From $100, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley Adjusts PT on Gilead Sciences to $151 From $147, Maintains Overweight Rating - marketscreener.com
Morgan Stanley Adjusts Biogen Price Target to $156 From $149, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley Adjusts Bristol-Myers Squibb PT to $37 From $36, Maintains Underweight Rating - marketscreener.com
Morgan Stanley keeps an equal weight rating on KLA Corporation (KLAC) - MSN
Morgan Stanley Analyst Is Bullish On Thermo Fisher Scientific Inc. (TMO) - Yahoo Finance
Morgan Stanley Keeps An Equal Weight Rating On KLA Corporation (KLAC) - Yahoo Finance UK
Got $1,000? 1 Tech Stock to Buy and Hold for Decades. - The Motley Fool
Meta Platforms price target lowered to $750 from $820 at Morgan Stanley - Yahoo Finance
Morgan Stanley price soarsForecast today12-12-2025 - Economies.com
RBC Raises Price Target on Morgan Stanley to $185 From $171, Keeps Sector Perform Rating - marketscreener.com
Coupang stock price target lowered to $31 by Morgan Stanley after data breach - Investing.com
Quantinno Capital Management LP Increases Position in Morgan Stanley $MS - MarketBeat
Planet Labs price target raised to $20 from $4.50 at Morgan Stanley - Investing.com UK
Morgan Stanley Raises Price Target on Ciena to $195 From $185, Keeps Equalweight Rating - marketscreener.com
Morgan Stanley Raises Price Target on Rhythm Pharmaceuticals to $150 From $129, Keeps Overweight Rating - marketscreener.com
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares - Investing.com
Coupang Inc (CPNG) PT Lowered to $31 at Morgan Stanley - StreetInsider
Synopsys stock price target raised to $550 from $510 at Morgan Stanley - Investing.com
Morgan Stanley Adjusts PT on Johnson & Johnson to $197 From $190, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals By Investing.com - Investing.com Canada
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares By Investing.com - Investing.com Canada
Morgan Stanley Adjusts Price Target on Pfizer to $28 From $32, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley Adjusts PT on Bank of America to $68 From $70, Maintains Overweight Rating - marketscreener.com
Morgan Stanley's long position in H-shares of Jiangsu Hengrui pharmaceuticals decreases to 2.76% on Dec 8HKEX - marketscreener.com
Canada Pension Plan Investment Board Cuts Holdings in Morgan Stanley $MS - MarketBeat
Morgan Stanley upgrades Lottomatica stock to Overweight on favorable outlook - Investing.com
Bayesian Capital Management LP Acquires New Holdings in Morgan Stanley $MS - MarketBeat
Broadcom stock price target raised to $462 by Morgan Stanley on AI growth - Investing.com
Will Maple Rock’s Exit and Morgan Stanley’s Caution Change Avis Budget Group's (CAR) Narrative? - simplywall.st
Morgan Stanley (MS): Revisiting Valuation After Analyst Upgrades and Growing Options Market Interest - Yahoo Finance
Morgan Stanley expects Macau 4Q GGR to grow 8pct sequentially - GGRAsia
Morgan Stanley: Debt financing on the cards for Genting Singapore with SG$5 billion still to spend on RWS 2.0 expansion - IAG – Inside Asian Gaming
Morgan Stanley Lowers Price Target for Evolution to 750 Kronor (830), Maintains Equal WeightBN - marketscreener.com
Morgan Stanley Stock After Hours (Dec. 11, 2025): MS Holds Near a 52-Week High Ahead of Dec. 12 Open — Fed Liquidity, Rate-Cut Path, and Key Levels to Watch - ts2.tech
Adani Power Gets Yet Another Bullish Call From Morgan Stanley — Check Target Price - NDTV Profit
Morgan Stanley Lowers Comcast (CMCSA) Target Amid Shifts in Wireless and Fiber Outlook - Insider Monkey
Verizon (VZ) edges lower in Morgan Stanley’s target reset amid competitive priorities - MSN
모건 스탠리 (MS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.43%
자본화:
|
볼륨(24시간):